Giant left atrium in a woman with mitral prosthetic valve malfunction and history of rheumatic heart disease

2009 ◽  
Vol 4 (5) ◽  
pp. 435-437
Author(s):  
Gaspare Parrinello ◽  
Daniele Torres ◽  
Salvatore Paterna ◽  
Manuela Mezzero ◽  
Pietro Di Pasquale ◽  
...  
Keyword(s):  
Heart Disease ◽  
Left Atrium ◽  
Rheumatic Heart Disease ◽  
Prosthetic Valve ◽  
History Of ◽  
Giant Left Atrium ◽  
Valve Malfunction ◽  
Rheumatic Heart

scholarly journals Giant Left Atrium in Rheumatic Heart Disease

1971 ◽  
Vol 174 (2) ◽  
pp. 194-201 ◽  
Author(s):  
J. PLASCHKES ◽  
J. B. BORMAN ◽  
G. MERIN ◽  
H. MILWIDSKY
Keyword(s):  
Heart Disease ◽  
Left Atrium ◽  
Rheumatic Heart Disease ◽  
Giant Left Atrium ◽  
Rheumatic Heart

scholarly journals Giant Left Atrium in Triple Rheumatic Heart Disease

2018 ◽  
Vol 13 ◽  
Author(s):  
Gëzim Berisha ◽  
Edmond Haliti ◽  
Gani Bajraktari
Keyword(s):  
Pulmonary Hypertension ◽  
Heart Disease ◽  
Mitral Valve ◽  
Left Atrium ◽  
Rheumatic Heart Disease ◽  
Heart Surgery ◽  
Open Heart Surgery ◽  
Heart Team ◽  
Giant Left Atrium ◽  
Rheumatic Heart

The giant left atrium (GLA) is a rare condition, commonly associated with rheumatic mitral valve disease, and very rarely with non rheumatic heart disease (nRHD). The triple valvular heart disease with involved mitral, aortic and tricuspid valves is quite uncommon. A 47 year female patient with a past medical history of rheumatic heart disease (RHD) and known severe mitral stenosis was with severe breathlessness (NYHA class IV). She had undergone mitral valve commissurotomy and tricuspid valve annuloplasty 12 years previously.  Transthoracic echocardiography revealed a giant left atrium, moderate to severe mitral valve restenosis, severe mitral regurgitation, moderate aortic regurgitation and severe tricuspid regurgitation, associated with severe secondary pulmonary hypertension and a markedly dilated right heart chambers. The patient was considered inoperable by the heart team, because of advanced pulmonary hypertension predicting a very high risk for open heart surgery. The final treatment decision was a difficult and complex issue.

scholarly journals Aetiology and Clinical Profile of Giant Left Atrium -- An Observational Study.

2021 ◽  
Author(s):  
AKM Monwarul Islam ◽  
A.A.S. Majumder ◽  
Shovan Rahman ◽  
Kaniz Ananya ◽  
Tanveer Ahmad ◽  
...  
Keyword(s):  
Heart Disease ◽  
Observational Study ◽  
Left Atrium ◽  
Rheumatic Heart Disease ◽  
Left Atrial ◽  
Tertiary Care ◽  
Volume Index ◽  
Giant Left Atrium ◽  
Rheumatic Heart

Background: The predominant cause of giant left atrium (GLA) is rheumatic mitral valvular disease. GLA is commonly defined echocardiographically by measuring the left atrial diameter (LAD). In the context of changing epidemiology of rheumatic heart disease (RHD) globally, and introduction of left atrial volume index (LAVI), the aetiology of GLA and utility of LAVI for defining GLA may be necessary. Methods: The prospective observational study was carried out at a dedicated tertiary care cardiac centre of a developing country to know the aetiology and clinical pattern of GLA over 8 years. GLA was defined echocardiographically as a left atrium (LA) having a diameter ≥80 mm in the left parasternal long-axis view. Follow-up was made over the telephone. Results: Thirty cases of GLA were diagnosed over 8 years from 2013 to 2021. Twenty two were due to rheumatic heart disease (RHD), 7 due to MVP, and 1 due to flail anterior mitral leaflet. Mean LAD was 92.13 ± 16.72 mm, and the mean LAVI was 288.77 ± 134.40 ml/m2. LA thrombus was present in 5 patients, 6 had spontaneous echo contrast (SEC) in LA, 2 had both LA thrombus and SEC. Mean follow-up was 0.99 ± 1.06 years. Out of 15 patients, 5 died, while 10 were alive. Mean survival was 1.8 ± 1.17 years, ranging from less than 1 year to 4 years. Conclusion: RHD continues to be the predominant cause of GLA; however, MVP is also important. The cut-off value of LAVI for defining GLA needs further study.

Giant Left Atrium in Rheumatic Heart Disease: The Classic Signs of Left Atrial Enlargement

2013 ◽  
Vol 44 (6) ◽  
pp. e393-e394 ◽  
Author(s):  
Jeffrey Forris Beecham Chick ◽  
Scott E. Sheehan ◽  
Jared D. Miller ◽  
Ryan J. Bair ◽  
Rachna Madan
Keyword(s):  
Heart Disease ◽  
Left Atrium ◽  
Rheumatic Heart Disease ◽  
Left Atrial ◽  
Left Atrial Enlargement ◽  
Atrial Enlargement ◽  
Giant Left Atrium ◽  
Rheumatic Heart

scholarly journals Largest giant left atrium in rheumatic heart disease

2020 ◽  
Author(s):  
Bhagya Narayan Pandit ◽  
Puneet Aggarwal ◽  
Siva Subramaniyan ◽  
Jaskaran Singh Gujral ◽  
Ranjit Kumar Nath
Keyword(s):  
Heart Disease ◽  
Left Atrium ◽  
Rheumatic Heart Disease ◽  
Giant Left Atrium ◽  
Rheumatic Heart

scholarly journals Presence of increased inflammatory infiltrates accompanied by activated dendritic cells in the left atrium in rheumatic heart disease

PLoS ONE ◽  
2018 ◽  
Vol 13 (9) ◽  
pp. e0203756 ◽  
Author(s):  
Mikio Shiba ◽  
Yasuo Sugano ◽  
Yoshihiko Ikeda ◽  
Hideshi Okada ◽  
Toshiyuki Nagai ◽  
...  
Keyword(s):  
Dendritic Cells ◽  
Heart Disease ◽  
Left Atrium ◽  
Rheumatic Heart Disease ◽  
Inflammatory Infiltrates ◽  
Rheumatic Heart

scholarly journals Validation of a simplified score for predicting latent rheumatic heart disease progression using a prospective cohort of Brazilian schoolchildren

BMJ Open ◽  
2020 ◽  
Vol 10 (5) ◽  
pp. e036827 ◽  
Author(s):  
Bárbara Martins Bechtlufft ◽  
Bruno Ramos Nascimento ◽  
Craig Sable ◽  
Clara Leal Fraga ◽  
Márcia Melo Barbosa ◽  
...  
Keyword(s):  
Heart Disease ◽  
Public Schools ◽  
Rheumatic Heart Disease ◽  
Heart Diseases ◽  
Diagnostic Category ◽  
Secondary Outcome ◽  
Unfavourable Outcome ◽  
History Of ◽  
Rheumatic Heart

ObjectivesEchocardiographic (echo) screening is an important tool to estimate rheumatic heart disease (RHD) prevalence, but the natural history of screen-detected RHD remains unclear. The PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática) study, which uses non-experts, telemedicine and portable echo, pioneered RHD screening in Brazil. We aimed to assess the mid-term evolution of Brazilian schoolchildren (5–18 years) with echocardiography-detected subclinical RHD and to assess the performance of a simplified score consisting of five components of the World Heart Federation criteria, as a predictor of unfavourable echo outcomes.SettingPublic schools of underserved areas and private schools in Minas Gerais, southeast Brazil.ParticipantsA total of 197 patients (170 borderline and 27 definite RHD) with follow-up of 29±9 months were included. Median age was 14 (12–16) years, and 130 (66%) were woman. Only four patients in the definite group were regularly receiving penicillin.Primary and secondary outcome measuresUnfavourable outcome was based on the 2-year follow-up echo, defined as worsening diagnostic category, remaining with mild definite RHD or development/worsening of valve regurgitation/stenosis.ResultsAmong patients with borderline RHD, 29 (17.1%) progressed to definite, 49 (28.8%) remained stable, 86 (50.6%) regressed to normal and 6 (3.5%) were reclassified as other heart diseases. Among those with definite RHD, 13 (48.1%) remained in the category, while 5 (18.5%) regressed to borderline, 5 (18.5%) regressed to normal and 4 (14.8%) were reclassified as other heart diseases. The simplified echo score was a significant predictor of RHD unfavourable outcome (HR 1.197, 95% CI 1.098 to 1.305, p<0.001).ConclusionThe simple risk score provided an accurate prediction of RHD status at 2-year follow-up, showing a good performance in Brazilian schoolchildren, with a potential value for risk stratification and monitoring of echocardiography-detected RHD.

Sign in / Sign up

Export Citation Format

Share Document